 Patients receive sunitinib malate orally PO once daily QD on days 1-28 and hydroxychloroquine PO once daily QD or twice daily BID on days 1-42 beginning day 4 of course 1. Treatment repeats every 42 days for 6 courses in the absence of disease progression or unacceptable toxicity. 